Breaking Finance News

Zacks Investment Research downgraded Swiss Re AG – ADR (NASDAQ:SSREY) to Sell in a report released today.

Zacks Investment Research has downgraded Swiss Re AG – ADR (NASDAQ:SSREY) to Sell in a report released on Friday September 23, 2016.

Just yesterday Swiss Re AG – ADR (NASDAQ:SSREY) traded 2.12% higher at $22.68. Swiss Re AG – ADR’s 50-day moving average is $21.45 and its 200-day moving average is $21.97. The last stock price is up 3.23% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 16,443 shares of the stock were exchanged, down from an avg. volume of 54,042

Performance Chart


With a total market value of $0, Swiss Re AG – ADR has price-earnings ratio of 7.96 with a one year low of $20.10 and a one year high of $25.10 .

Brief Synopsis About Swiss Re AG – ADR (NASDAQ:SSREY)

Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company's clients include insurance companies, mid- to large-sized corporations and public sector clients. Its segments include Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Admin Re. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments. The Corporate Solutions segment is engaged in serving mid-sized and large corporations, with product offerings ranging from traditional property and casualty insurance to customized solutions. The Admin Re segment provides risk and capital management solutions by which the Company acquires closed books of in-force life and health insurance business, entire lines of business, or the entire capital stock of life insurance companies. The Company's open and closed life insurance books, including Admin Re, are managed under a unit called Life Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *